Envision Healthcare
EVHC
Delayed Nyse - 02/21 05:49:02 pm
38.15USD
+2.03%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Sales3 6967 780
EBITDA631887
Operating profit (EBIT)568796
Pre-Tax Profit (EBT)--
Net income-27,7-342
EPS ( $ )-0,47-1,40
Dividend per Share ( $ )--
Yield--
Announcement Date02/28/2017
09:15pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Debt5 5074 293
Finance--
Operating income (EBITDA)631887
Leverage
(Debt/EBITDA)
8,73x4,84x
Capital Expenditure99,5139
Book Value Per Share (BVPS)57,3 $55,9 $
Cash Flow per Share6,66 $6,88 $
Announcement Date02/28/2017
09:15pm
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 4 561 M$ -
Entreprise Value (EV) 8 854 M$ 8 761 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 15,9x
Capitalization / Revenue 0,59x 0,55x
EV / Revenue 1,14x 1,06x
EV / EBITDA 9,98x 9,54x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 0,67x 0,65x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 10,2% 9,84%
operating Leverage (Delta EBIT / Delta Sales) 0,36x 0,35x
Net Margin (Net Profit / Revenue) -4,40% 3,25%
ROA (Net Profit / Asset) 2,82% 3,00%
ROE (Net Profit / Equities) 5,13% 4,98%
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,79% 1,07%
Cash Flow / Sales 10,7% 6,09%
Capital Intensity (Assets / Sales) -1,56x 1,08x
Financial Leverage (Net Debt / EBITDA) 4,84x 4,57x
Price Earning Ratio
BNA & Dividende